GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports - Finance news and analysis from Global Banking & Finance Review
Finance

Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports

Published by Global Banking & Finance Review

Posted on November 19, 2026

1 min read

· Last updated: November 19, 2026

Add as preferred source on Google

Sanofi Reportedly Weighs Takeover Bid for US Drugmaker Insmed

Sanofi's Potential Acquisition of Insmed

Overview of the Report

Nov 19 (Reuters) - Sanofi is weighing an acquisition of US drugmaker Insmed, Bloomberg News reported on Thursday, citing people familiar with the matter.

Market Reaction and Company Responses

Insmed's Market Valuation

Shares of Insmed, which has a market valuation of $26.28 billion according to LSEG data, were up 16%. The companies did not immediately respond to Reuters' requests for comment.

Sanofi's Deliberations

French drugmaker Sanofi is speaking with advisers as it studies a potential deal for Insmed, Bloomberg reported, citing the people, who asked not to be identified discussing confidential information.

Timeline and Ongoing Discussions

 Deliberations are ongoing and any deal could still be weeks away, the report added.

Reporting Credits

(Reporting by Sneha S K; Editing by Maju Samuel)

Key Takeaways

  • Sanofi is assessing a takeover of Insmed, with talks involving advisers underway; any deal remains speculative and may take weeks to materialize, with no guarantee of completion (in.investing.com)
  • Insmed’s market capitalization stands at approximately $26.28 billion as of November 18, 2026 (stockanalysis.com)
  • Insmed shares surged—by over 6%—after the takeover report, underscoring investor optimism, though both firms have declined to comment (in.investing.com)

References

Frequently Asked Questions

What is Sanofi considering regarding Insmed?
Sanofi is weighing an acquisition of US drugmaker Insmed, according to reports.
What is Insmed's current market valuation?
Insmed has a market valuation of $26.28 billion, based on LSEG data.
How did Insmed's shares react to the news?
Shares of Insmed rose 16% following news of a potential acquisition.
Are the talks between Sanofi and Insmed confirmed?
While discussions are ongoing, the companies have not confirmed any deal, and deliberations may take weeks.
Who reported the potential Sanofi-Insmed deal?
The potential deal was reported by Bloomberg News, citing people familiar with the matter.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category